EnginZyme
PrivateLast Round
Series C
Sep 23, 2026
Total Funding Raised
$47.21M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
EnginZyme is a biotechnology company that develops cell-free synthetic technology to enable sustainable biomanufacturing for the chemical industry.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EnginZyme Comparables
Compare EnginZyme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FabricNano | 81% | |
| Debut | 79% | |
| Enzymicals AG | 79% |
EnginZyme Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 23, 2026 | ||||
| Series B | Dec 19, 2022 | ||||
| Series A Extension | Feb 11, 2021 | ||||
| Series A | Apr 21, 2020 | ||||
| Grant | Jan 1, 2020 |
Key People
Founding team and executive leadership
EnginZyme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bunge Ventures | Series B |
| SEB Group | Series A Extension, Series B |
| Navigare Ventures | Series C, Series B |
| Almi Invest AB | Series C, Series B |
| Industrifonden | Series C, Series B, Series A Extension |
| European Union's Horizon 2020 research and innovation programme (Marie Skłodowska-Curie) | Grant |
| Sofinnova Partners | Series C, Series A Extension, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
$9M round led by Valquest Partners
- Aug 21, 2026
Monthly visitors grew 181% MoM, reaching 6.9K.
EnginZyme Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EnginZyme's valuation, stock price, and market status.
Is EnginZyme a public or private company?
EnginZyme is a private company.
What is the current stock price of EnginZyme?
EnginZyme is a private company with no public stock price. No recent secondary market data is available.
How much is EnginZyme worth (valuation)?
Valuation information for EnginZyme is not publicly available.
Can I buy EnginZyme stock?
EnginZyme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EnginZyme's last funding round?
EnginZyme's most recent funding round was Series B on December 19, 2022.
Who are the main investors in EnginZyme?
Key investors in EnginZyme include Industrifonden, Sofinnova Partners.
Will EnginZyme IPO soon?
No public IPO plans have been announced for EnginZyme.
How can I track EnginZyme secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EnginZyme's secondary market activity and sign up for updates.